Heterogeneity, Bayesian thinking, and phenotyping in critical care: A primer

Area of Science:

• Critical care medicine
• Clinical research methodology
• Statistical analysis

Background:

• Numerous critical care trials have yielded negative results, prompting a need for improved research strategies.
• Heterogeneity in treatment effects and patient populations complicates clinical trial interpretation.
• Existing research methods struggle to address the complexities of critical care patient variability.

Purpose of the Study:

• To introduce clinicians to Bayesian thinking and phenotyping in critical care research.
• To explain the clinical relevance of these emerging concepts in addressing trial limitations.
• To highlight how Bayesian analysis and phenotyping can improve evidence quality and treatment personalization.

Main Methods:

• Bayesian statistical analyses provide probabilistic interpretations of treatment effects, aiding clinical decision-making.
• Phenotyping identifies specific patient traits to target interventions, enhancing treatment efficacy.
• These methods are being integrated into adaptive clinical trials and predictive enrichment strategies.

Main Results:

• Bayesian analyses offer interpretive power by summarizing treatment effects based on probabilities of benefit or harm.
• Phenotyping, including subphenotyping, is crucial for heterogeneous conditions like acute respiratory distress syndrome and sepsis.
• Data from physiological parameters, biomarkers, and genomics inform patient grouping and targeted therapies.

Conclusions:

• Bayesian thinking and phenotyping are essential for the future of critical care medicine.
• These approaches enhance the value of current and future research by managing heterogeneity.
• Clinicians need to understand these methods to improve decision-making in complex critical care scenarios.